Cargando…
Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks
Atorvastatin (AT) is a widely used lipid-regulating drug to reduce cholesterol and triglycerides. Its poor aqueous solubility and hepatic metabolism require development of drug delivery systems able to improve its solubility and bypass hepatic effect. For this purpose, atorvastatin nanostructured li...
Autores principales: | Elmowafy, Mohammed, Ibrahim, Hany M., Ahmed, Mohammed A., Shalaby, Khaled, Salama, Ayman, Hefesha, Hossam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241136/ https://www.ncbi.nlm.nih.gov/pubmed/28617150 http://dx.doi.org/10.1080/10717544.2017.1337823 |
Ejemplares similares
-
Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies
por: Elmowafy, Mohammed, et al.
Publicado: (2021) -
SN38 loaded nanostructured lipid carriers (NLCs); preparation and in vitro evaluations against glioblastoma
por: Shirazi, Ali Sabouri, et al.
Publicado: (2021) -
Development of Triamcinolone Acetonide-Loaded Nanostructured Lipid Carriers (NLCs) for Buccal Drug Delivery Using the Box-Behnken Design
por: Kraisit, Pakorn, et al.
Publicado: (2018) -
Cannabidiol-Loaded Nanostructured Lipid Carriers (NLCs) for Dermal Delivery: Enhancement of Photostability, Cell Viability, and Anti-Inflammatory Activity
por: Morakul, Boontida, et al.
Publicado: (2023) -
Formulation And Evaluation Of Nanostructured Lipid Carriers (NLCs) Of 20(S)-Protopanaxadiol (PPD) By Box-Behnken Design
por: Kim, Min-Hwan, et al.
Publicado: (2019)